Long-Time Novavax, Inc. Board Member Jack Marsh Assumes Role of Director Emeritus

GAITHERSBURG, Md., June 18, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that on June 12, 2014, the Honorable John O. Marsh, Jr., resigned as a member of its Board of Directors. Mr. Marsh joined the Board of Novavax in August 1991 and served as the company's interim CEO and Chairman of the Board from 1996 to 1997. At various times during his 23 years as a Board member, he has served on all of the Board's various committees. According to company records kept since 2005, Jack's attendance rate at Board meetings was in excess of 90%; Mr. Marsh has attended every board of directors meeting in person or by telephone since 2010. In recognition of his 23 years of service, the Board of Directors has named Mr. Marsh Director Emeritus.

Help employers find you! Check out all the jobs and post your resume.